BCG Vaccine Related Clinical Trials
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients [Recruiting]
Bacille Calmette Gu�rin Immunisation at Birth and Childhood Morbidity in Danish Children. [Recruiting]
Study of AERAS 422 in Healthy Adults [Recruiting]
BCG Vaccination Delivered Intradermally, Orally and by Combined Routes [Recruiting]
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer [Recruiting]
Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma [Recruiting]
Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer [Recruiting]
Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder [Recruiting]
Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination [Recruiting]
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer [Recruiting]
Bacille Calmette-Guérin (BCG) Vaccine and Atopy [Recruiting]
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI) [Recruiting]
Sex-Differential Health Interventions In Low-Birth-Weight Infants [Recruiting]
Preclearance of Latent Tuberculosis Infection With INH and BCG vs. BCG Alone [Recruiting]
Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer [Recruiting]
Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults [Recruiting]
Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG for Superficial Bladder Cancer [Recruiting]
Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa [Recruiting]
Vitamin D Supplementation Enhances Immune Response to Bacille-Calmette-Guerin (BCG) Vaccination in Infants [Recruiting]
Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression [Not yet recruiting]
Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers [Recruiting]
Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine [Recruiting]
Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants [Recruiting]
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers [Recruiting]
Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe [Not yet recruiting]
Vitamin A Supplementation at Birth and Atopy in Childhood [Recruiting]
Markers of Response to Intravesical Bladder Cancer Therapy [Recruiting]
Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function [Recruiting]
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route [Recruiting]
Stage IV Surgery Versus Best Medical Therapy [Recruiting]
Diagnosis of Active Tuberculosis by ELISPOT [Recruiting]
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer [Recruiting]
Biomarker Discovery and Application in Bladder Cancer [Recruiting]
Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients [Recruiting]
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer [Recruiting]
|
